New hope for patients with Fast-Growing blood cancer
NCT ID NCT07220187
Summary
This study is testing if adding a new drug called pirtobrutinib to standard chemotherapy works better for treating Richter transformation. Richter transformation is when a slow-growing blood cancer suddenly turns into a much faster-growing and aggressive lymphoma. The trial will enroll 102 adults who have not yet received treatment for this aggressive form. Researchers want to see if the new combination helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RICHTER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.